• Issue

    Liver International: Volume 29, Issue 7

    955-1128
    August 2009
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Review Article

Free Access

Liver cancer stem cells: implications for a new therapeutic target

Terence Kin Wah Lee,  Antonia Castilho,  Stephanie Ma,  Irene Oi Lin Ng, 
  • Pages: 955-965
  • First Published: 02 July 2009

Basic Studies

Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin

Stephen N. Hartland,  Frank Murphy,  Rebecca L. Aucott,  Armand Abergel,  Xiaoying Zhou,  Julian Waung,  Nishit Patel,  Catherine Bradshaw,  Jane Collins,  Derek Mann,  R. Christopher Benyon,  John P. Iredale, 
  • Pages: 966-978
  • First Published: 02 July 2009

Impaired liver regeneration with humoral and genetic disturbances in urinary trypsin inhibitor-deficient mice

Takayuki Nobuoka,  Toru Mizuguchi,  Hideki Oshima,  Toshihito Shibata,  Shinsuke Kaji,  Minoru Nagayama,  Makoto Meguro,  Toshihiro Mitaka,  Koichi Hirata, 
  • Pages: 979-987
  • First Published: 02 July 2009

Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue

Hiroshi Kudo,  Yutaka Yata,  Terumi Takahara,  Kengo Kawai,  Yasuhiro Nakayama,  Masami Kanayama,  Takeshi Oya,  Seiichi Morita,  Masakiyo Sasahara,  Derek A. Mann,  Toshiro Sugiyama, 
  • Pages: 988-996
  • First Published: 02 July 2009

Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice

Giovanni Latella,  Antonella Vetuschi,  Roberta Sferra,  Valentina Catitti,  Angela D'Angelo,  Giuliana Zanninelli,  Kathleen C. Flanders,  Eugenio Gaudio, 
  • Pages: 997-1009
  • First Published: 02 July 2009

Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes

Bryan L. Copple,  Juan J. Bustamante,  Timothy P. Welch,  Nam Deuk Kim,  Jeon-Ok Moon, 
  • Pages: 1010-1021
  • First Published: 02 July 2009

Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation

Hussein M. Atta,  Ayman Al-Hendy,  Salama A. Salama,  Olfat G. Shaker,  Olfat A. Hammam, 
  • Pages: 1022-1030
  • First Published: 02 July 2009

Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression

Giammarco Fava,  Sharon DeMorrow,  Eugenio Gaudio,  Antonio Franchitto,  Paolo Onori,  Guido Carpino,  Shannon Glaser,  Heather Francis,  Monique Coufal,  Luca Marucci,  Domenico Alvaro,  Marco Marzioni,  Trenton Horst,  Romina Mancinelli,  Antonio Benedetti,  Gianfranco Alpini, 
  • Pages: 1031-1042
  • First Published: 02 July 2009

Liver International Image

Esophageal variceal bleeding in a patient with tuberculosis

Chih-Feng Lin,  Rich Yi-Chen Hsu,  Tsai-Yuan Hsieh,  Heng-Cheng Chu, 
  • Page: 1043
  • First Published: 02 July 2009

Clinical Studies

Diabetic hepatosclerosis: a 10-year autopsy series

Guilan Chen,  Elizabeth M. Brunt, 
  • Pages: 1044-1050
  • First Published: 02 July 2009

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection

Gerardo Alvarez-Uria,  Jeremy N. Day,  Anisa J. Nasir,  Susan K. Russell,  Francisco Javier Vilar, 
  • Pages: 1051-1055
  • First Published: 02 July 2009

The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma

Hirotake Takai,  Atsuhiko Kato,  Chie Kato,  Takeshi Watanabe,  Koichi Matsubara,  Masami Suzuki,  Hiroaki Kataoka, 
  • Pages: 1056-1064
  • First Published: 02 July 2009

Schistosoma mansoni coinfection could have a protective effect against mixed cryoglobulinaemia in hepatitis C patients

Omaima M. Abbas,  Nabil A. Omar,  Hassan E. Zaghla,  Mohammad F. Faramawi, 
  • Pages: 1065-1070
  • First Published: 02 July 2009

Effect of hyponatraemia on outcomes following orthotopic liver transplantation

William A. Hackworth,  Douglas M. Heuman,  Arun J. Sanyal,  Robert A. Fisher,  Richard K. Sterling,  Velimir A. Luketic,  Mitchell L. Shiffman,  Daniel G. Maluf,  Adrian H. Cotterell,  Marc P. Posner,  Richard T. Stravitz, 
  • Pages: 1071-1077
  • First Published: 02 July 2009

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease

Masato Yoneda,  Kikuko Hotta,  Yuichi Nozaki,  Hiroki Endo,  Takashi Uchiyama,  Hironori Mawatari,  Hiroshi Iida,  Shingo Kato,  Koji Fujita,  Hirokazu Takahashi,  Hiroyuki Kirikoshi,  Noritoshi Kobayashi,  Masahiko Inamori,  Yasunobu Abe,  Kensuke Kubota,  Satoru Saito,  Shiro Maeyama,  Koichiro Wada,  Atsushi Nakajima, 
  • Pages: 1078-1085
  • First Published: 02 July 2009

Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C

Chao-Hung Hung,  Chuan-Mo Lee,  Chien-Hung Chen,  Tsung-Hui Hu,  Shu-Rong Jiang,  Jing-Houng Wang,  Sheng-Nan Lu,  Pei-Wei Wang, 
  • Pages: 1086-1093
  • First Published: 02 July 2009

Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease

Marina G. Silveira,  Flavia D. Mendes,  Nancy N. Diehl,  Felicity T. Enders,  Keith D. Lindor, 
  • Pages: 1094-1100
  • First Published: 02 July 2009

Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial

Lei Chen,  Tianli Xiao,  Wensheng Chen,  Qingling Long,  Rongjun Li,  Dianchun Fang,  Rongquan Wang, 
  • Pages: 1101-1109
  • First Published: 02 July 2009

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study

Puneeta Tandon,  Karli Moncrief,  Karen Madsen,  Marie C. Arrieta,  Richard J. Owen,  Vince G. Bain,  Winnie W. Wong,  Mang M. Ma, 
  • Pages: 1110-1115
  • First Published: 02 July 2009

Case Report

A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice)

Mats Gåfvels,  Petra Holmström,  Anna Somell,  Fredrik Sjövall,  Jan-Olof Svensson,  Lars Ståhle,  Ulrika Broomé,  Per Stål, 
  • Pages: 1116-1124
  • First Published: 02 July 2009

Letters to the Editors

Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver

Sorabh Kapoor,  Ralf Bahde, 
  • Page: 1125
  • First Published: 02 July 2009

Letters to the Editor

Re: Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver

Jun Yu,  Eagle S. H. Chu, 
  • Pages: 1125-1126
  • First Published: 02 July 2009

Which level of immunosuppression is harmful for occult hepatitis B virus infection?

Ersan Ozaslan, 
  • Pages: 1126-1127
  • First Published: 02 July 2009

Which level of immunosuppression is harmful for occult hepatitis B virus infection?: ‘A million dollar’ answer

Sarah P. Georgiadou,  George N. Dalekos, 
  • Pages: 1127-1128
  • First Published: 02 July 2009